US 10894077
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted A61KA61K38/52A61K48/0066
Quick answer
US patent 10894077 (Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K38/52, A61K48/0066